Podiatrists in Warrensville Heights, OH Accepting Medicare
3 Podiatrists found. Showing 1 - 3
 Dr. Joel Novack, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 20050 Harvard Road, Suite 205, Warrensville Heights, OH 44122 Phone: 216-491-9157 Fax: 216-491-7245 |
 Joel Novack Dpm, Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 20050 Harvard Rd, Suite 205, Warrensville Heights, OH 44122 Phone: 216-491-9151 Fax: 216-491-7243 |
Brian J Novack Dpm Inc Podiatrist - Foot Surgery Medicare: Medicare Enrolled Practice Location: 20050 Harvard Ave Ste 105, Warrensville Heights, OH 44122 Phone: 216-491-9151 Fax: 216-491-7243 |
News Archive
NIH awards contract to develop nanotechnology tools for atherosclerosis treatment
Georgia Tech and Emory University have received a five-year $14.6 million contract from the National Institutes of Health (NIH) to continue the development of nanotechnology and biomolecular engineering tools and methodologies for detecting and treating atherosclerosis.
Using a health information exchange network to enhance disease surveillance
How do public health officials know if there is a disease outbreak and where that outbreak has occurred?
Breakfast not the most important meal for weight loss
A new study has busted the common belief that breakfast is the most important meal of the day for people trying to lose weight.
ZIOPHARM receives Notice of Allowance for palifosfamide from U.S. patent office
ZIOPHARM Oncology, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for Application Serial No. 11/257,766 entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to compounds, pharmaceutical compositions, and lyophilisates. These claims cover the Company's proprietary palifosfamide composition (ZIO-201 or ZymafosTM). The Company has recently reported positive randomized Phase II sarcoma interim data for intravenous palifosfamide at the Annual Meeting of the Connective Tissue Oncology Society (CTOS) on November 6, 2009 and expects, following U.S. Food and Drug Administration (FDA) review, to initiate a registration trial the first half of 2010.
› Verified 3 days ago
Occupational Therapists
Physical Therapists
Speech-Language Pathologists
Chiropractors
Podiatrists
Audiologists